Knowledge of the evolving methods of transarterial radioembolization and the tools to assess posttreatment imaging and response is essential for radiologists to optimize this therapeutic option for... Transarterial radioembolization (TARE) with yttrium 90 has increasingly been performed to treat hepatocellular carcinoma (HCC). TARE was historically used as a palliative lobar therapy for patients...